Reuters logo
BRIEF-Cipla gets final approval for generic Pulmicort Respules
November 17, 2017 / 3:28 AM / a month ago

BRIEF-Cipla gets final approval for generic Pulmicort Respules

Nov 17 (Reuters) - Cipla Ltd:

* Cipla receives final approval for generic Pulmicort Respules

* Drug indicated for maintenance treatment of asthma, as prophylactic therapy in children 12 months to 8 years of age

* Product available for shipping immediately Source text: bit.ly/2A5o1QM Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below